scispace - formally typeset
D

Dina Sabry

Researcher at Cairo University

Publications -  233
Citations -  3665

Dina Sabry is an academic researcher from Cairo University. The author has contributed to research in topics: Mesenchymal stem cell & Stem cell. The author has an hindex of 26, co-authored 206 publications receiving 2770 citations. Previous affiliations of Dina Sabry include Mansoura University & University of Toledo.

Papers
More filters
Journal ArticleDOI

The Clinical Use of Human Culture–Expanded Autologous Bone Marrow Mesenchymal Stem Cells Transplanted on Platelet-Rich Fibrin Glue in the Treatment of Articular Cartilage Defects: A Pilot Study and Preliminary Results

TL;DR: Testing the hypothesis that platelet-rich fibrin glue can be used clinically as a scaffold to deliver autologous culture-expanded bone marrow mesenchymal stem cells (BM-MSCs) for cartilage repair and to report clinical results 1 y after implantation of MSCs PR-FG found it to be effective.
Journal ArticleDOI

Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases

TL;DR: Administration of cell-free cord-blood mesenchymal stem cells derived extracellular vesicles (CF-CB-MSCs-EVs) is safe and can ameliorate the inflammatory immune reaction and improve the overall kidney function in grade III-IV CKD patients.
Journal ArticleDOI

Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis.

TL;DR: Results of the present study showed that MSC have a potential therapeutic effect against the fibrotic process through their effect in minimizing collagen deposition in addition to their capacity to differentiate into hepatocytes.
Journal ArticleDOI

Homing and reparative effect of intra-articular injection of autologus mesenchymal stem cells in osteoarthritic animal model

TL;DR: Homing was confirmed by the incorporation of injected GFP-labeled MSCs within the repaired newly formed cartilage, proving that the use of IA injection of autologous M SCs is a viable and a practical option for treating different degrees of osteoarthritis.
Journal ArticleDOI

Mesenchymal Stem Cell-Derived Exosomes Ameliorated Diabetic Nephropathy by Autophagy Induction through the mTOR Signaling Pathway.

TL;DR: Autophagy induction by exosomes could attenuate DN in a rat model of streptozotocin-induced diabetes mellitus and markedly improved renal function and showed histological restoration of renal tissues.